✦ LIBER ✦

A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum

✍ Scribed by J.V. BROWN III; M.A. RETTENMAIER; K.L. LOPEZ; C. GRAHAM; J.P. MICHA; B. GOLDSTEIN

Book ID: 109086202
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 93 KB
Volume: 18
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2007.01001.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

A phase II clinical trial of topotecan a

A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer

✍ F. VECCHIONE; R. FRUSCIO; T. DELL’ANNA; A. GARBI; R. GARCIA PARRA; S. CORSO; A.A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

A multicenter, Phase II trial of weekly

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

✍ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9

Phase I/II trial of combination therapy

Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer

✍ Seisuke Inada; Takashi Tomidokoro; Hiroyuki Fukunari; Tomomi Sato; Toru Hatano; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 320 KB

A Phase II trial of paclitaxel and topot

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

✍ J. Marc Pipas; Louise P. Meyer; C. Harker Rhodes; Laurence D. Cromwell; Carol E. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 286 KB

Phase II trial of weekly locoregional hy

Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix

✍ Ron C. Rietbroek; Marten S. Schilthuis; Piet J. M. Bakker; Jan D. P. van Dijk; A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 3 views

## Phase II Trial of Weekly Locoregional Hyperthermia and Cisplatin in Patients with a Previously Irradiated Recurrent Carcinoma of the Uterine Cervix BACKGROUND. The biologic rationale for combining cisplatin with locoregional Ron C